AbbVie Stock Will $300: Timing and Risks to Watch
AbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Regularly reviewing your savings progress is essential for success. Discover effective methods to keep track of your financial journey.
20,681 articlesAbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Analysts clash over SpaceX's value as Oppenheimer targets a $250 price, while Michael Burry stays neutral. The debate...
Strong U.S. jobs data rekindled concerns about liquidity in crypto markets. The resilient jobs market keeps policy in...
Despite renewed fatal-accident headlines, Tesla’s core growth story remains intact, with rising deliveries and softwa...
Bank of America’s macro team expects the Fed to deliver three 25-basis-point hikes this year, pushing rates higher an...
A focused screen uncovers a small group of high-yielding stocks trading double-digit discounts, offering both steady ...
Walmart announced a $1.4 billion purchase of Vibe.co, a French ad-tech company. The move expands Walmart Connect into...
Lucid's stock sits near a critical pricing zone as its balance sheet frays and dilution fears mount, even as producti...
Ethereum slid to multi-month lows as crypto markets flash renewed risk-off signals. Analysts warn that the sell-off c...
As AI accelerates, tech’s demand uninterrupted power is forcing investors to rethink NextEra Energy’s renewables-led ...
Cleveland Fed President Beth Hammack signals a hawkish tilt, arguing inflation and a tight labor market could justify...
Robinhood shares surged after several brokerages initiated coverage with Buy ratings as the broader crypto rebound li...